Page last updated: 2024-08-25

clarithromycin and Bacterial Infections

clarithromycin has been researched along with Bacterial Infections in 94 studies

Research

Studies (94)

TimeframeStudies, this research(%)All Research%
pre-19909 (9.57)18.7374
1990's50 (53.19)18.2507
2000's23 (24.47)29.6817
2010's9 (9.57)24.3611
2020's3 (3.19)2.80

Authors

AuthorsStudies
Agouridas, C; Bonnefoy, A; Bonnet, A; Bretin, F; Denis, A; Fromentin, C; Piltan, G1
Alihodzić, S; Andreotti, D; Berge, JM; Cipcić Paljetak, H; Derek, M; Dumić, M; Eraković Haber, V; Fajdetić, A; Holmes, DJ; Hutinec, A; Lazarevski, G; Lociuro, S; Marsić, N; Mutak, S; Spaventi, R; Stimac, V; Sunjić, V1
Almayah, AA; Bolandnazar, Z; Ebrahimi, A; Ebrahimi, HP; Hadi, JS; Swadi, AG1
Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB1
Chen, X; Cheng, Y; Dai, Q; Lin, H; Liu, G; Ma, X; Pang, X; Xie, L; Yan, X; Ye, J; Zhang, X; Zhao, Q1
Agius, JE; Emery, JP; Phalen, DN; Rose, K1
Shibayama, K; Tsutsui, A; Yahara, K1
Abebe, W; Moges, F; Molla, R; Tiruneh, M1
Amighi, K; De Bueger, V; Pilcer, G; Sebti, T; Traina, K; Traore, H; Vanderbist, F1
Baconnet, B; Léophonte, P; Perronne, C; Zuck, P1
Benden, C; Boehler, A1
Alexander, RE; Grogan, DM1
Frydendall, N; Gluud, C; Hansen, JF; Hilden, J; Jespersen, CM; Kolmos, HJ1
Bono, BR; Qamar, F; Zuckerman, JM1
Hasan, SM; Hassan, F; Khan, NW; Naqvi, BS1
Lindeboom, JA1
Baranowski, WJ1
Weiss, LR1
Freudenstein, J; Hauke, W; Henneicke-Von Zepelin, HH; Köhler, G1
Blum, S; Sauter, C1
Busman, T; Dobryniewska, M; Nalepa, P; Notario, G1
Zuckerman, JM2
Gotfried, MH1
Miravitlles, M; Torres, A1
Eller, J; Ioanas, M; Linnhoff, A; Lode, H1
Ebisawa, K; Ishida, H; Kakoi, H; Kure, H; Kure, M; Saitoh, H; Takemura, Y1
Ariyürek, M; Doğru, D; Firat, P; Göçmen, A; Gürcan, N; Kiper, N; Mocan, G; Ozçelik, U; Sahin, A; Yalçin, E1
Altraja, A; Kullamaa, A; Leesik, H; Meriste, S; Naaber, P; Tamm, E1
Ferekidis, E; Maragoudakis, P; Nikolopoulos, TP; Tzagaroulakis, A; Vlastarakos, PV1
Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Jackson, J; Kong, L; Kropp, H; Shankaran, K; Smith, JG; Wilkening, R1
Burnham, LB; Citron, DM; Goldstein, EJ; Inderlied, CB; Kenner, MA1
Appelbaum, PC; Jacobs, MR; Spangler, SK1
Calì, G; Consoli, G; Rossetti, B; Valenti, D1
Schlossberg, D1
Akita, H; Aoyama, T; Fujii, R; Iwata, S; Meguro, H; Satoh, Y; Sunakawa, K; Takeuchi, Y; Terashima, I; Yokota, T1
Barza, M; Eisenberg, E1
Parent, M1
Rodriguez, WJ; Wiedermann, BL1
Demartini, G; Fraschini, F; Scaglione, F1
Dubois, J; Saint-Pierre, C; Tremblay, C1
Narita, N1
Vetter, N; Waardenburg, FA; Wettengel, R1
Coles, SJ; James, I; Kearsley, NJ; Macklin, JL1
Holdcroft, C1
Hammerschlag, MR1
Müller, O1
Bradbury, F1
Hosie, J; Quinn, P; Sides, G; Smits, P1
Klein, JO1
Nightingale, CH1
Block, SL; Harris, J; Kolokathis, A; Tarlow, MJ1
Vagliasindi, M1
Deguchi, K; Fukumoto, T; Ishihara, R; Ishii, Y; Matsumoto, Y; Nakane, Y; Nakazawa, A; Nishinari, C; Suzuki, Y1
Appelbaum, PC; Ednie, LM; Jacobs, MR1
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y1
Wiedermann, BL1
Gangadharam, PR1
Esposito, S; Principi, N1
Adelglass, J; Henry, DC; Jablonski, CK; Moller, DJ; Scheld, WM; Talbot, GH; Zhang, H1
Clifford, K; Echols, RM; Heyd, A; Huck, W; Shan, M; Tosiello, R1
Anzueto, A; Grossman, RF; Rizzo, JA1
Furunishi, M; Kita, E; Maeda, K; Mashima, T; Mikasa, K; Narita, N; Sakamoto, M; Ueta, K1
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, K; Warren, Y1
Adam, D; Brueckner, OJ; Glaser-Caldow, E; Hein, J; Hirsch, J; Kroemer, B; Wachter, J1
Prescott, LM1
McCarty, JM; Pierce, PF1
Neu, HC1
Danziger, LH; Piscitelli, SC; Rodvold, KA1
Tunkel, AR; Whitman, MS1
Clissold, SP; Peters, DH1
Craft, JC; Guay, DR1
Chonmaitree, T; Hedgpeth, D; Horlick, D; Howie, VM; Owen, MJ; Patel, JA1
Poirier, R1
Aldons, PM1
Anderson, G; Carnegie, C; Coles, S; Esmonde, TS; Macklin, J1
Bachand, RT1
Acar, J; Baquero, F; Bergan, T; Forsgren, A; Phillips, I; Wiedemann, B1
Gooch, G; Ho, D; Rolston, K1
Kawahira, M; Kobayashi, H; Miura, H; Nakaike, S; Otomo, S; Takeda, H1
Abe, T; Arimasu, O; Fujii, R; Higa, A; Hiruma, F; Meguro, H; Shinozaki, T; Sugamata, K; Sugie, N1
Akita, H; Iwata, S; Sato, Y; Sunakawa, K1
Matsumoto, K; Nakanishi, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H1
Aramaki, M; Fujimoto, T; Kawakami, A; Koga, T; Kuroiwa, Y; Motohiro, T; Oda, K; Sakata, Y; Shimada, Y; Tanaka, K1
Abe, T; Arimasu, O; Fujii, R; Higa, A; Hiruma, F; Meguro, H; Shinozaki, T; Sugamata, K; Sugie, N; Sunagawa, K1
Ikeshima, K; Morihana, T; Morishima, T; Noma, H; Sakamoto, H; Sasaki, J; Shiiki, K; Takai, H; Tomita, F; Uematsu, M1
Bailer, R; Bower, RR; Fernandes, PB; Gade, E; Hanson, CW; Hardy, D; McDonald, E; Ramer, N; Shipkowitz, N; Swanson, R1

Reviews

21 review(s) available for clarithromycin and Bacterial Infections

ArticleYear
Long-acting erythromycins: assessing their role in treating outpatient odontogenic infections.
    Texas dental journal, 2009, Volume: 126, Issue:4

    Topics: Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Delayed-Action Preparations; Erythromycin; Humans; Tooth Diseases

2009
Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
    Infectious disease clinics of North America, 2009, Volume: 23, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides; Minocycline; Tetracyclines; Tigecycline

2009
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.
    Infectious disease clinics of North America, 2004, Volume: 18, Issue:3

    Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides

2004
Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.
    Expert review of anti-infective therapy, 2003, Volume: 1, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Humans; Tablets

2003
Biofilms in ear, nose, and throat infections: how important are they?
    The Laryngoscope, 2007, Volume: 117, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Infections; Biofilms; Chronic Disease; Clarithromycin; Cochlear Implants; Combined Modality Therapy; Erythromycin; Foreign Bodies; Humans; Middle Ear Ventilation; Otitis Media with Effusion; Pharynx; Phenotype; Prosthesis-Related Infections; Sinusitis

2007
Azithromycin and clarithromycin.
    The Medical clinics of North America, 1995, Volume: 79, Issue:4

    Topics: Azithromycin; Bacterial Infections; Clarithromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests

1995
Azithromycin and clarithromycin.
    Current clinical topics in infectious diseases, 1994, Volume: 14

    Topics: Animals; Azithromycin; Bacterial Infections; Biological Availability; Clarithromycin; Drug Interactions; Half-Life; Humans; Microbial Sensitivity Tests; Tissue Distribution

1994
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
    Advances in pediatric infectious diseases, 1994, Volume: 9

    Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans

1994
Clarithromycin clinical pharmacokinetics.
    Clinical pharmacokinetics, 1993, Volume: 25, Issue:3

    Topics: Absorption; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Biological Availability; Child; Clarithromycin; Drug Interactions; Drug Tolerance; Humans; Middle Aged

1993
[Recent progress on diagnosis and therapy of diffuse panbronchiolitis].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Mar-10, Volume: 82, Issue:3

    Topics: Adult; Aged; Bacterial Infections; Bronchiolitis; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged

1993
Azithromycin and clarithromycin.
    Pediatric annals, 1993, Volume: 22, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests

1993
History of macrolide use in pediatrics.
    The Pediatric infectious disease journal, 1997, Volume: 16, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Interactions; Erythromycin; Haemophilus Infections; Haemophilus influenzae; History, 20th Century; Humans; Infant; Infant, Newborn; Microscopy, Electron; Phagocytes; Phagocytosis

1997
Pharmacokinetics and pharmacodynamics of newer macrolides.
    The Pediatric infectious disease journal, 1997, Volume: 16, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Ear, Middle; Haemophilus Infections; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Streptococcal Infections; Tissue Distribution

1997
Future indications for macrolides.
    The Pediatric infectious disease journal, 1997, Volume: 16, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Helicobacter Infections; Humans; Malaria; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial

1997
Macrolides: clarithromycin and azithromycin.
    Pediatrics in review, 1998, Volume: 19, Issue:7

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gastrointestinal Diseases; Humans; Male

1998
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Drug safety, 1999, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Hypersensitivity; Drug Interactions; Erythromycin; Humans; Liver Function Tests

1999
[Clinical application of the new action of macrolide preparations to respiratory diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Aug-10, Volume: 88, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Immunologic Factors; Lung Neoplasms

1999
The newer macrolides: azithromycin and clarithromycin.
    Infectious disease clinics of North America, 2000, Volume: 14, Issue:2

    Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans

2000
Clarithromycin and azithromycin: new macrolide antibiotics.
    Clinical pharmacy, 1992, Volume: 11, Issue:2

    Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Interactions; Drug Labeling; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria

1992
Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Infection control and hospital epidemiology, 1992, Volume: 13, Issue:6

    Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious

1992
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Drugs, 1992, Volume: 44, Issue:1

    Topics: Aged; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant

1992

Trials

29 trial(s) available for clarithromycin and Bacterial Infections

ArticleYear
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Coronary Disease; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Patient Compliance; Placebos; Young Adult

2009
Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jan-15, Volume: 52, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Face; Female; Humans; Infant; Lymphadenitis; Male; Neck; Rifabutin; Time Factors; Treatment Outcome

2011
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Clinical therapeutics, 2002, Volume: 24, Issue:9

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome

2002
Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
    Chemotherapy, 2002, Volume: 48, Issue:5

    Topics: Adjuvants, Immunologic; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Humans; Lung Diseases, Obstructive; Pilot Projects; Plant Extracts; Roxithromycin; Time Factors

2002
Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Current medical research and opinion, 2003, Volume: 19, Issue:5

    Topics: Acute Disease; Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Clarithromycin; Delayed-Action Preparations; Double-Blind Method; Drug Resistance, Bacterial; Humans; Middle Aged; Patient Compliance; Treatment Outcome

2003
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
    The European respiratory journal, 2004, Volume: 24, Issue:6

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome

2004
Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count.
    Journal of clinical pathology, 2005, Volume: 58, Issue:7

    Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Biomarkers; C-Reactive Protein; Cephalosporins; Clarithromycin; Fever; Humans; Japan; Leukocyte Count; Middle Aged; Outpatient Clinics, Hospital; Practice Patterns, Physicians'; Respiratory Tract Infections; Treatment Outcome

2005
Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchiectasis; Bronchoalveolar Lavage Fluid; Child; Clarithromycin; Colony Count, Microbial; Female; Humans; Interleukin-10; Interleukin-8; Leukocyte Count; Male; Respiratory Function Tests; Sputum; Tumor Necrosis Factor-alpha

2006
[Clinical studies on clarithromycin dry syrup in the pediatric field. Pediatric Study Group of TE-031 Dry Syrup].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:10

    Topics: Administration, Oral; Adolescent; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Female; Humans; Infant; Intestinal Absorption; Male

1994
Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis.
    Ear, nose, & throat journal, 1993, Volume: 72, Issue:12

    Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Bacterial Infections; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Single-Blind Method; Treatment Outcome

1993
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Cefaclor; Clarithromycin; Double-Blind Method; Female; Humans; Male; Middle Aged

1993
A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections.
    Journal of chemotherapy (Florence, Italy), 1993, Volume: 5, Issue:3

    Topics: Amoxicillin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Respiratory Tract Infections; Single-Blind Method; Suspensions

1993
Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl E

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Administration Schedule; Erythromycin; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis

1993
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl E

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Bronchitis; Clarithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections

1993
A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:1

    Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Macrolides; Male; Middle Aged; Patient Compliance; Single-Blind Method

1995
Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
    International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Culture Media; Double-Blind Method; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Reference Standards; Respiratory Tract Infections

1997
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group.
    Clinical therapeutics, 1999, Volume: 21, Issue:2

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis

1999
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
    The Annals of otology, rhinology, and laryngology, 1999, Volume: 108, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome

1999
Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Clinical therapeutics, 2001, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chemistry, Pharmaceutical; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Treatment Outcome

2001
Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2001, Volume: 87, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefprozil; Cephalosporins; Clarithromycin; Demography; Double-Blind Method; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Treatment Outcome

2001
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Drugs, 1992, Volume: 44, Issue:1

    Topics: Aged; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant

1992
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
    Journal of internal medicine, 1992, Volume: 231, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chi-Square Distribution; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome

1992
Effect of viral respiratory tract infection on outcome of acute otitis media.
    The Journal of pediatrics, 1992, Volume: 120, Issue:6

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefpodoxime; Ceftizoxime; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Treatment Outcome; Virus Diseases

1992
Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl A

    Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Remission Induction; Roxithromycin

1991
A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl A

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged

1991
A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl A

    Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia

1991
Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl A

    Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Remission Induction; Sputum

1991
[Bacteriological, pharmacokinetic and clinical studies on clarithromycin in the pediatric field. Pediatric Study Group of Clarithromycin].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:2

    Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Multicenter Studies as Topic

1989
[Clinical evaluation of clarithromycin in treatment of acute dental infections. Comparative double-blind study using josamycin as the control].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Clarithromycin; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Humans; Leucomycins; Male; Middle Aged; Multicenter Studies as Topic; Tooth Diseases

1989

Other Studies

45 other study(ies) available for clarithromycin and Bacterial Infections

ArticleYear
Beta-keto-ester chemistry and ketolides. Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides.
    Bioorganic & medicinal chemistry letters, 2000, Sep-04, Volume: 10, Issue:17

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Macrolides; Mice; Structure-Activity Relationship

2000
4''-O-(omega-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens.
    Bioorganic & medicinal chemistry, 2010, Sep-01, Volume: 18, Issue:17

    Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Propionates

2010
Metal-based biologically active azoles and β-lactams derived from sulfa drugs.
    Bioorganic & medicinal chemistry, 2016, Mar-01, Volume: 24, Issue:5

    Topics: Anti-Bacterial Agents; Azoles; Bacteria; Bacterial Infections; beta-Lactams; Coordination Complexes; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Schiff Bases; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles

2016
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
    Journal of medicinal chemistry, 2020, 06-25, Volume: 63, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides

2020
Photoacoustic Imaging-Trackable Magnetic Microswimmers for Pathogenic Bacterial Infection Treatment.
    ACS nano, 2020, 03-24, Volume: 14, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Drug Resistance, Multiple, Bacterial; Fluorescent Dyes; Indoles; Klebsiella pneumoniae; Magnetic Phenomena; Mice; Microbial Sensitivity Tests; Optical Imaging; Photoacoustic Techniques; Phototherapy; Polymers; Spirulina

2020
Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics.
    Scientific reports, 2021, 07-05, Volume: 11, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Models, Animal; Enrofloxacin; Enterococcus; Humans; Lizards

2021
Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:6

    Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Clarithromycin; Drug Utilization; Fluoroquinolones; Humans; Infusions, Parenteral; Japan; Macrolides; Product Surveillance, Postmarketing; Sulfamethoxazole; World Health Organization

2018
Clarithromycin in patients with coronary artery disease.
    The Medical letter on drugs and therapeutics, 2018, 05-21, Volume: 60, Issue:1547

    Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacterial Infections; Clarithromycin; Coronary Artery Disease; Humans; Risk Factors

2018
Bacterial profile and antimicrobial susceptibility patterns in chronic suppurative otitis media at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    BMC research notes, 2019, Jul-15, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Ciprofloxacin; Clarithromycin; Ethiopia; Hospitals, Special; Hospitals, University; Humans; Microbial Sensitivity Tests; Norfloxacin; Otitis Media, Suppurative; Proteus mirabilis; Staphylococcus aureus

2019
Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis.
    International journal of pharmaceutics, 2013, Jul-15, Volume: 451, Issue:1-2

    Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Crystallization; Cystic Fibrosis; Drug Combinations; Drug Compounding; Drug Synergism; Dry Powder Inhalers; Lung; Lung Diseases; Microscopy, Electron, Scanning; Particle Size; Powders; Tissue Distribution; Tobramycin; X-Ray Diffraction

2013
[Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].
    Medecine et maladies infectieuses, 2008, Volume: 38, Issue:9

    Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Child; Clarithromycin; Delayed-Action Preparations; Disease Progression; Drug Tolerance; Female; France; Humans; Middle Aged; Physicians, Family; Pulmonary Disease, Chronic Obstructive; Rural Population; Smoking; Urban Population

2008
Long-term clarithromycin therapy in the management of lung transplant recipients.
    Transplantation, 2009, May-27, Volume: 87, Issue:10

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchiolitis Obliterans; Child; Clarithromycin; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Young Adult

2009
Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
    Pakistan journal of pharmaceutical sciences, 2011, Volume: 24, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Diffusion; Erythromycin; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Proteus; Staphylococcus aureus

2011
Clarithromycin-induced hypersomnia in children.
    International journal of clinical pharmacology and therapeutics, 2011, Volume: 49, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Child, Preschool; Clarithromycin; Disorders of Excessive Somnolence; Female; Humans; Male; Narcolepsy

2011
Antibiotics for heart health?
    Health news (Waltham, Mass.), 2002, Volume: 8, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; Chest Pain; Clarithromycin; Coronary Artery Disease; Humans; Inflammation

2002
Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease.
    American journal of clinical oncology, 2003, Volume: 26, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Female; Hodgkin Disease; Humans; Lung Neoplasms; Reed-Sternberg Cells

2003
[Fluoroquinolone superior to macrolide. Longer infection free period after acute bronchitis].
    MMW Fortschritte der Medizin, 2003, Feb-13, Volume: 145, Issue:7

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clarithromycin; Double-Blind Method; Follow-Up Studies; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Recurrence

2003
Antibiotics in exacerbations of COPD: lessons from the past.
    The European respiratory journal, 2004, Volume: 24, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic

2004
Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Estonia; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae

2006
In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    The Journal of antibiotics, 1995, Volume: 48, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Drug Evaluation, Preclinical; Drug Stability; Erythromycin; Female; Half-Life; Klebsiella Infections; Macrolides; Mice; Mice, Inbred DBA; Molecular Structure; Staphylococcal Infections; Streptococcal Infections

1995
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20 Suppl 2

    Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae; Child; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Clostridium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam; Ticarcillin

1995
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:5

    Topics: Agar; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Oxygenases; Roxithromycin

1995
[Clarithromycin in the treatment of oral infections].
    Minerva stomatologica, 1994, Volume: 43, Issue:9 Suppl 1

    Topics: Adolescent; Adult; Aged; Bacterial Infections; Clarithromycin; Drug Evaluation; Humans; Middle Aged; Mouth Diseases; Remission Induction; Tooth Diseases

1994
[Initial empiric treatment of pneumonia and the new antibiotics].
    L'union medicale du Canada, 1994, Volume: 123, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Pneumonia

1994
Two new macrolide antibiotics: clarithromycin and azithromycin.
    The Nurse practitioner, 1993, Volume: 18, Issue:1

    Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Costs; Erythromycin; Humans

1993
[Antimicrobial activities of clarithromycin against recent obtained clinical isolates].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:9

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Humans; Time Factors

1997
Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Oxygenases

1998
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom

1998
Clarithromycin for non-mycobacterial diseases?
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1998, Volume: 2, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium Infections; Risk Assessment

1998
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:6

    Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; Time Factors

1999
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:11

    Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin

1999
Macrolides, azalides, and streptogrammins.
    Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin

1996
New macrolide antibiotics: azithromycin and clarithromycin.
    Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6

    Topics: Animals; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans

1992
Studies show new macrolide antibiotics to be superior to some older agents.
    Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Quinolones

1992
Two macrolide antimicrobials approved for marketing.
    Clinical pharmacy, 1992, Volume: 11, Issue:2

    Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; United States; United States Food and Drug Administration

1992
Clarithromycin and azithromycin.
    The Medical letter on drugs and therapeutics, 1992, May-15, Volume: 34, Issue:870

    Topics: Azithromycin; Bacterial Infections; Clarithromycin; Clinical Trials as Topic; Erythromycin; Humans; Microbial Sensitivity Tests

1992
Clinical results using two new antibiotics--clarithromycin and temafloxacin.
    Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Opportunistic Infections; Quinolones

1991
ESGAB breakpoint determination: clarithromycin.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:11

    Topics: Bacteria; Bacterial Infections; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mycoplasma pneumoniae

1991
In-vitro activity of clarithromycin (A-56268; TE-031) against gram-positive bacteria.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:3

    Topics: Bacterial Infections; Clarithromycin; Erythromycin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms

1989
[Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1989, Volume: 63, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Clarithromycin; Erythromycin; Female; Humans; Killer Cells, Natural; Male; Middle Aged; Time Factors

1989
[Clinical evaluation of clarithromycin, a new macrolide antibiotic in children].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:2

    Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Half-Life; Humans; Infant; Male

1989
[Laboratory and clinical studies on clarithromycin in pediatrics].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:2

    Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections

1989
[Pharmacokinetic, bacteriological and clinical studies in the pediatric field on clarithromycin].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:2

    Topics: Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Half-Life; Humans; Infant; Male

1989
[Clinical study on clarithromycin granule and tablet in the field of pediatrics].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:2

    Topics: Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male

1989
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:6

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Drug Combinations; Drug Synergism; Erythromycin; Female; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Injections, Subcutaneous; Kinetics; Legionella; Legionnaires' Disease; Male; Mice; Microbial Sensitivity Tests; Sulfamethoxazole

1986